Fig. 1.
Treatment with AT-RvD1 post-disease onset restored saliva flow rates in SS-like mice
Mice were treated as described in ‘Methods’. Whole saliva was then collected using an intraperitoneal injection with pilocarpine (40 mg/kg) and isoproterenol (0.4 mg/kg). Results are representative of n = 5 mice/condition and data expressed as mean ± SD, with *P < 0.05 indicating a significant difference from controls. AT-RvD1: aspirin-triggered resolvin D1.